Evidence map›Paper›PMID 29222697›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR.

Anneloes L van Rijn, Roel H T Nijhuis, Vincent Bekker, Geert H Groeneveld, Els Wessels, Mariet C W Feltkamp, Eric C J Claas

Open access · hybridAbstract readComparative Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. A multicenter evaluation of the QIAstat-Dx meningitis-encephalitis syndromic test kit as compared to the conventional diagnostic microbiology workflow.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  4. Article
  5. Impact of multiplexed respiratory viral panels on infection control measures and antimicrobial stewardship: a review of the literature.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Review
  6. Article
  7. Health Care-Acquired Viral Respiratory Diseases.Infectious disease clinics of North America · 2021
    Review
  8. Article
  9. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The GenMark ePlexFuture microbiology · 2018
    Review
  16. Innovative DendrisChipsDiagnostics (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anneloes L van RijnDepartment of Medical Microbiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. a.l.van_rijn-klink@lumc.nl.
Roel H T NijhuisDepartment of Medical Microbiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Vincent BekkerDepartment of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
Geert H GroeneveldDepartment of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Els WesselsDepartment of Medical Microbiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Mariet C W FeltkampDepartment of Medical Microbiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Eric C J ClaasDepartment of Medical Microbiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. e.c.j.claas@lumc.nl.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid diagnosis of respiratory infections is of great importance for adequate isolation and treatment. Due to the batch-wise testing, laboratory-developed real-time polymerase chain reaction (PCR) assays (LDT) often result in a time to result of one day. Here, LDT was compared with rapid ePlex® Respiratory Pathogen (RP) Panel testing of GenMark Diagnostics (Carlsbad, CA, USA) with regard to time to result, installed isolation precautions, and antibacterial/antiviral treatment. Between January and March 2017, 68 specimens of 64 patients suspected of an acute respiratory infection were tested with LDT and the ePlex® RP panel. The time to result was calculated as the time between sample reception and result reporting. Information regarding isolation and antibacterial/antiviral treatment was obtained from the patient records. Thirty specimens tested LDT positive (47%) and 29 ePlex® RP panel positive (45%). The median time to result was 27.1 h (range 6.5-96.6) for LDT versus 3.4 h (range 1.5-23.6) for the RP panel, p-value < 0.001. In 14 out of 30 patients, isolation was discontinued based on the ePlex® RP panel results, saving 21 isolation days. ePlex® RP panel test results were available approximately one day ahead of the LDT results in the 19 patients receiving antiviral/antibacterial treatment. In addition, two bacterial pathogens, not requested by the physician, were detected using the RP panel. Analysis of respiratory infections with the ePlex® RP panel resulted in a significant decrease in time to result, enabling a reduction in isolation days in half of the patients. Furthermore, syndromic RP panel testing increased the identification of causative pathogens.

Indexed as

Molecular Diagnostic TechniquesPolymerase Chain ReactionRespiratory Tract InfectionsAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsAntiviral AgentsChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleAnti-Bacterial AgentsAntiviral Agents

Identifiers

PMID29222697
PMCPMC5816761
OpenAlexW2773317252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.